The DOI matches its Crossref record; 119 of the 124 references it cites were found in a registry or an index.
Cytochrome P450 Enzymes and Drug Metabolism in Humans
Open accessAbstract
Human cytochrome P450 (CYP) enzymes, as membrane-bound hemoproteins, play important roles in the detoxification of drugs, cellular metabolism, and homeostasis. In humans, almost 80% of oxidative metabolism and approximately 50% of the overall elimination of common clinical drugs can be attributed to one or more of the various CYPs, from the CYP families 1–3. In addition to the basic metabolic effects for elimination, CYPs are also capable of affecting drug responses by influencing drug action, safety, bioavailability, and drug resistance through metabolism, in both metabolic organs and local sites of action. Structures of CYPs have recently provided new insights into both understanding the mechanisms of drug metabolism and exploiting CYPs as drug targets. Genetic polymorphisms and epigenetic changes in CYP genes and environmental factors may be responsible for interethnic and interindividual variations in the therapeutic efficacy of drugs. In this review, we summarize and highlight the structural knowledge about CYPs and the major CYPs in drug metabolism. Additionally, genetic and epigenetic factors, as well as several intrinsic and extrinsic factors that contribute to interindividual variation in drug response are also reviewed, to reveal the multifarious and important roles of CYP-mediated metabolism and elimination in drug therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These enzymes are responsible for metabolizing 70% of clinically prescribed drugs22,23, establishing this timepoint as pivotal for investigating drug metabolism, interactions, and toxicity.”
From Temporal proteomic profiling of iPSC-derived human liver organoids reveals optimal maturation for drug metabolism and toxicology (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
Nelson, D. R., Koymans, L. M. H., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,946
Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0637 · Cited by 2,356
Conney, A. H. (1982) · PubMed · Cited by 1,557
Ingelman‐Sundberg, M., Sim, S. C., Gomez, A. V., & Rodríguez‐Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,180
Ingelman‐Sundberg, M. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500285 · Cited by 1,111
Predicting in vivo drug interactions from in vitro drug discovery data
Wienkers, L. C., & Heath, T. G. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1851 · Cited by 910
Cytochrome P450 Structure, Function and Clinical Significance: A Review
Palrasu, M., & Nagini, S. (2017) · Current Drug Targets · doi:10.2174/1389450118666170125144557 · Cited by 855
Inhibition and Induction of Cytochrome P450 and the Clinical Implications
Lin, J. H., & Lu, A. Y. H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00003 · Cited by 827
The Cytochrome P450 Superfamily: Biochemistry, Evolution and Drug Metabolism in Humans
Danielson, B. S. P. P. B. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337054 · Cited by 775
Cited by
Sorted by citations
Items 501–600 of 999
From millets to medicine: ADMET insights into diabetes management with P. sumatrense compounds
Lakhani, K. G., Prajapati, P., Hamid, R., Patel, S., Dwivedi, A., & Suthar, K. P. (2024) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2024.103396 · Cited by 3
Chen, G., Xin, Y., Hammour, M. M., Braun, B., Ehnert, S., Springer, F., Vosough, M., Menger, M. M., Kumar, A., Nussler, A. K., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03899-9 · Cited by 3
Thankan, R. S., Thomas, E. B., Weldemariam, M. M., Purushottamachar, P., Huang, W., Kane, M. A., Zhang, Y., Ambulos, N. P., Wang, B., Weber, D. J., et al. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70009 · Cited by 3
Self-citationShriwas, P., Revnew, A., Roo, S., Bender, A., Miller, K. A., Hadad, C. M., Lane, T. R., Ekins, S., & McElroy, C. A. (2025) · Molecules · doi:10.3390/molecules30092032 · Cited by 3
Li, M., Sanderson, B. J., Hackett, J. L., Niyangoda, S. S., Gong, H., Johnson, M. A., & Wang, M. Z. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100099 · Cited by 3
Self-citationDesign and synthesis of hydroxychloroquine-sugar conjugates as promising antimalarial agents
Salim, E., Ilmi, H., Widyawaruyanti, A., & Oka, N. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130289 · Cited by 3
Olubamiwa, A. O., Ma, J., Dehanne, P., Noban, C., Angın, Y., Barberan, O., & Chen, M. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2514537 · Cited by 3
Self-citationSolaimanian, S., Rahmani, B., & Shiri‐Shahsavar, M. R. (2023) · Research Square · doi:10.21203/rs.3.rs-3376948/v1 · Cited by 3
Deep mutational scanning of CYP2C19 reveals a substrate specificity-abundance tradeoffPreprint
Boyle, G. E., Sitko, K. A., Galloway, J., Haddox, H. K., Bianchi, A. H., Dixon, A., Thomson, R. E. S., Garge, R. K., Rettie, A. E., Rubin, A. F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.06.561250 · Cited by 3
Farmacogenómica: Una puerta de acceso a la medicina personalizada
Cacabelos, R. (2023) · Medicina Clínica · doi:10.1016/j.medcli.2023.11.008 · Cited by 3
Physiology, Pathophysiology, and Anesthetic Management of Patients with Hepatic Disease
Paranjape, V. V., & Garcia‐Pereira, F. L. (2024) · doi:10.1002/9781119830306.ch40 · Cited by 3
Influence of gut microbiota on oral drug absorption and metabolismPreprint
Nelson, D. A., Veerareddy, V., Kashyap, P., Tang, X., Kalari, K. R., & Kandimalla, K. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.16.638186 · Cited by 3
TMT-Based Proteomics Analysis Revealed the Protein Changes in Perirenal Fat from Obese Rabbits
Jiang, G., Shao, J., Tang, T., Wang, M., Wang, J., Jia, X., & Lai, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417167 · Cited by 2
Androgen Signaling in Prostate Cancer: When a Friend Turns Foe
Pandey, S. K., Sabharwal, U., Tripathi, S., Mishra, A., Yadav, N., & Dwivedi‐Agnihotri, H. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303313528240523101940 · Cited by 2
Toxicological effects of Honokiol on zebrafish and its underlying mechanism
Lin, J., Liu, H. H., Huang, X., & Deng, Y. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23789 · Cited by 2
Li, Y., Xu, Q., Jian, G.-L., Zhang, X.-L., & Wang, H. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01632 · Cited by 2
Chong, C. L., Fang, C.-M., Pung, S., Ong, C. E., Pung, Y. F., Kong, C., & Pan, Y. (2024) · Journal of Nanoparticle Research · doi:10.1007/s11051-024-06184-z · Cited by 2
Garrido-Palazuelos, L. I., Aguirre-Sánchez, J. R., Sandoval-González, M. F., Mukhtar, M., Guerra-Meza, O., & Khan, H. A. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01329-w · Cited by 2
Maheta, D., Agrawal, S. P., Patel, J., Patel, M., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000848 · Cited by 2
A Case of Olanzapine Resistance from Heavy Smoking and Clinical Considerations
Surineni, K., Smith, A. B., Glein, R. M., & Schrader, N. (2025) · Kansas Journal of Medicine · doi:10.17161/kjm.vol18.22846 · Cited by 2
Shen, Y., Wang, Y.-H., Liou, K., Wei, W., Cheng, J., Liu, H., Huang, N., Lo, I., Chang, C.-C., Chiou, W., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1596785 · Cited by 2
Shrestha, R. L., Tamang, A., Poudel, M., Shiva, M. C., Parajuli, N., Shrestha, A., Shrestha, T., Bharati, S., Maharjan, B., Marasini, B. P., et al. (2025) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2025.109105 · Cited by 2
Gomes, A. K. C., Fiorot, R. G., Gomes, A. C. C., & Simas, N. K. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2529558 · Cited by 2
Telbisz, Á., Kaci, H., Bakos, É., Nagymihály, Z., Both, E. B., Lambert, N., Özvegy-Laczka, C., & Poór, M. (2025) · ACS Omega · doi:10.1021/acsomega.5c05217 · Cited by 2
DDI–CYP: Metabolism ensemble models for drug-drug interaction predictions
Wong, J. T., Harris, J. S., Lane, T. R., Urbina, F., & Ekins, S. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100137 · Cited by 3
Nasser, M. S. A., Ahmad, M. A. A. A. S., Edris, S., Abdelfattah, E. H., Ali, A. S., Zaitoun, M. F., Alharbi, F. H., Mahdi, H. B. A., & Damanhouri, Z. A. (2025) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-025-00035-1 · Cited by 2
Haque, M. U., Alam, A. K., Rahman, M. A. A., Islam, M. S., Jibon, M. D. K., Sujon, K. M., Roqunuzzaman, M., Rahman, M. M., Box, M. I., Khatun, M. M., et al. (2025) · Results in Chemistry · doi:10.1016/j.rechem.2025.102694 · Cited by 2
Quercetin and Its Structural Analogs as NUDT5 Inhibitors: A Preliminary In Silico Study
Gligorić, E. I., Vidić, M., Teofilović, B. D., & Grujić-Letić, N. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188843 · Cited by 2
Finger, V., Vrbický, M., Múčková, Ľ., Prchal, L., Novák, M., Marek, J., Soukup, O., Hympánová, M., Sorf, A., Benková, M., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118537 · Cited by 2
Mass spectrometry-based absolute quantitative proteomics of drug-metabolizing enzymes in human liver
McCalla, Z., & Wang, X. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108929 · Cited by 2
Ghosh, J., Alshahrani, A. M., Palodhi, A., Bhattacharyya, D., Das, S., Mondal, S. K., Kalam, A., Ahmad, S. R., & Mal, C. (2025) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2025.1567748 · Cited by 2
Albishri, S., Hammami, B., Mohamed, S. A., Algreiby, A. A., Aouadi, K., & Kadri, A. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144107 · Cited by 2
Research on the content and activity of CYP450 enzymes in human liver
Zhang, C., Fang, Y., Jia, L.-J., & Qiao, H. (2025) · Drug Metabolism Reviews · doi:10.1080/03602532.2025.2568231 · Cited by 2
Investigation of the regulatory effects of tea polyphenols on CYP450s in HepG2 cells
Zuo, D., Ren, H., Ren, Z., Chen, J., Wang, F., Zhang, Z., & Sun, H. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1663800 · Cited by 2
Jeon, J., Jarrell, Z. R., Lee, C., Singer, G., Weinberg, J., Liu, K., Morgan, E. T., Go, Y., & Jones, D. P. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100183 · Cited by 2
Pratama, Y. A., Marhaeny, H. D., Winarto, S., Palmado, I. A., Widyananda, M. H., Rahmadi, M., Taher, M., Hasan, A. A., Kleuser, B., & Khotib, J. (2025) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_117_25 · Cited by 2
Ali, I. J., Olofinsan, K. A., Ikeh, G. O., Okorie, N. H., Adonu, C., Omeh, R. C., Idoko, B. C., & Nnamani, P. E. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202502342 · Cited by 2
Usin, S. G., Nwankwo, D. O., Ruggah, A. H., Adebesin, A. O., Ali, M. A., Ayeni, T. O., Ohilebo, A. A., Aiyelabegan, A. O., Campos, O. C. D., Raheem, K. Y., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-03541-9 · Cited by 2
Jacob, D., Gradhand, U., Maurer, C. K., Scheible, H., Stelz, C., Hagel, M., Nachtigall, J., Lang, B., Richter, L. H. J., Massière, F., et al. (2025) · Xenobiotica · doi:10.1080/00498254.2025.2587283 · Cited by 2
Naheed, S., Hussain, K., Wajid, M., Zubair, H., Shehzadi, N., Zulfiqar, U., Awais, S., & Muhammad, G. (2025) · ChemistrySelect · doi:10.1002/slct.202501871 · Cited by 2
Computational profiling of flavonoids against key breast cancer targets: an in-silico exploration
Praise, S. A., Olusanya, M. M., Kolawole, A., Awolesi, A. B., Igbin, C. O., Egunjobi, G. D., Bakare, O. S., Ezeuchenne, I. C., & Musibau, J. A. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00489-0 · Cited by 3
Perez, J., Gonzalez, M., & Ramirez, S. (2024) · Specialty Journal of Pharmacognosy, Phytochemistry, and Biotechnology · doi:10.51847/rmgserramc
Therapeutic Potential and Predictive Pharmaceutical Modeling of Indole Kratom Alkaloids
Rashid, M. H., Williams, M. J., Guerra, A. G., Itharat, A., Löebenberg, R., & Davies, N. M. (2025) · Journal of Phytomedicine · doi:10.3390/jphytomed1010001 · Cited by 2
Zhu, R., Tang, J., Jing, Y., Ou, L., Zou, Z., Luo, C., & Feng, X. L. (2026) · Animal Nutriomics · doi:10.1017/anr.2025.10019 · Cited by 2
Schimith, L. E., Martis, E., Télétchéa, S., Muccillo-Baisch, A. L., André‐Miral, C., & Hort, M. A. (2026) · ACS Omega · doi:10.1021/acsomega.5c08887 · Cited by 2
Degechisa, S. T., & Baye, T. M. (2026) · Human Genomics · doi:10.1186/s40246-025-00878-8 · Cited by 2
Albetawi, S., Meakin, A. S., Lien, Y., Wiese, M. D., Simmons, R. A., & Morrison, J. L. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117786 · Cited by 2
Gu, S., Dou, Z., Shen, H., Zhang, H., Ba, Y., Gu, J., & Zhang, P. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1752553 · Cited by 2
Single-cell insights into cisplatin resistance mechanisms in bladder cancer tumor microenvironment
Xu, L., Lin, Y., Shi, G., Zhang, L., Lin, X., & Zhang, T. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111304 · Cited by 2
The Venom Revolution in Biomedicine: Unlocking Nature’s Toxin Toolkit for Therapeutic Innovation
Bose, D., Srinivasan, K., Patil, S. S., Nayak, A. G., & Hariharapura, R. C. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102227 · Cited by 2
An Overview of Endometriosis and Potential Pharmacogenetic Targets
Pérez-Gómez, N., Martínez‐Zamora, M. Á., Carmona, F., Novalbos, J., Abad‐Santos, F., Koller, D., & Saiz‐Rodríguez, M. (2026) · Pharmaceutical Research · doi:10.1007/s11095-026-04049-9 · Cited by 2
Toxicological aspects of emerging nitazene analogues as a new threat to the synthetic drug landscape
Martins, J. N., dos Santos, B. P., & Arbo, M. D. (2026) · Discover Toxicology · doi:10.1007/s44339-026-00050-4 · Cited by 3
D, K. H. M., Mamada, H., Nakayama, S., Mizuno, T., Iwata, H., Esaki, T., & Kosugi, Y. (2026) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2026.101532 · Cited by 2
Implications of Genetic Elements on Type 2 Diabetes Mellitus Pathogenesis and Management
Ngcobo, N. N., & Sibiya, N. H. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70204 · Cited by 3
Hendrickx, S., Ilbeigi, K., Thoré, E. S. J., Bertram, M. G., Calvo-Alvarez, E., Cintesun, S., Olías-Molero, A. I., Corral, M. A., Mateo, M., Estaquier, J., et al. (2026) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkag111 · Cited by 2
Berikkhanova, K., Inuwa, I., Taigulov, E., Kozhakhmetov, S., Bikhanov, N., Omarbekov, A., Berikkhanova, G., Sultan, Y., Jibo, A. G., Abdrakhmanova, S. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114978 · Cited by 2
Molecular studies on the impact of microbiome on anticancer drug resistance
Zhou, K., Lu, P., Xu, H., Wang, L., & Liang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1848345 · Cited by 2
Clemente‐Suárez, V. J., Beltrán-Velasco, A. I., Ramos‐Campo, D. J., Rubio-Zarapuz, A., Tornero-Aguilera, J. F., Martín-Rodríguez, A., Sepulveda, R. A. Y., & López-Gil, J. F. (2026) · SAGE Open Medicine · doi:10.1177/20503121261462838 · Cited by 3
CYP450 network shifts in MASLD/MASH: from pathogenesis to nutrition-informed modulation
Koç, S., Toydemir, S., Vardar, G., Öter, G. N., & Yusufoğlu, B. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110459 · Cited by 3
Pharmacokinetic Interactions in Synergistic Herb-Drug Combinations
Hemaiswarya, S., Prabhakar, P. K., & Doble, M. (2022) · Springer eBooks · doi:10.1007/978-981-19-5125-1_4 · Cited by 2
Watanabe, K., Kondo, M., Ikenaka, Y., Nakayama, S. M. M., & Ishizuka, M. (2023) · Animals · doi:10.3390/ani13121939 · Cited by 2
Ellis, C., Inaba, K., de Vuurst, C. V., Ghrayeb, A., & Cory, T. J. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2267970 · Cited by 2
Sun, P., Cao, Y., Qiu, J., Kong, J., Zhang, S., & Cao, X. (2023) · Molecules · doi:10.3390/molecules28207193 · Cited by 2
Transport and Metabolism of Xenobiotics in the Urban Ecosystem
Paul, S., Ghosh, U., & Saha, M. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-35775-6_4 · Cited by 3
Sun, J. M., Li, R., Zhang, J., Huang, Y., Lü, Y., Li, Y., Li, Y., & Liu, T. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115899 · Cited by 2
Leveraging in Vitro Models for Clinically Relevant Rare CYP2D6 Variants in Pharmacogenomics
Stern, S., Hyland, P. L., Pacanowski, M. A., & Schuck, R. N. (2024) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001512 · Cited by 2
Althaher, A. R., Jarrar, Y. B., Al-Ibadah, M. A., Balasmeh, R., Jarrar, Q., & Abulebdah, D. (2024) · MicroRNA · doi:10.2174/0122115366268781231205103752 · Cited by 2
Establishing national reference materials for genetic testing of cytochrome P450
Jia, Z., Huang, J., Yang, Y. T., Yang, Y., Wei, L., Qu, S., Sun, N., Zhang, W., Han, L., & Huang, J. (2024) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000532 · Cited by 2
El-Said, K. S., & El-Feki, S. M. (2024) · Biological and Biomedical Journal · doi:10.21608/bbj.2024.263771.1030 · Cited by 2
Lourenço, T. M. G., Marques, L., Ribeiro, E., & Vale, N. (2024) · BioMed · doi:10.3390/biomed4020015 · Cited by 2
Alnoor, A. A., Abdalla, A. N., Bar, F. M. A., Hamdi, O. A. A., Elzubier, M. E., Mohmed, H. H. A., Salkini, M. A., Kuse, M., Moglad, E. H. O., & Mira, A. (2024) · Arab Journal of Basic and Applied Sciences · doi:10.1080/25765299.2024.2370093 · Cited by 2
Seo, J. I., Kwak, Y. B., Cho, S. E., & Yoo, H. H. (2024) · Planta Medica · doi:10.1055/a-2363-5033 · Cited by 2
Shankar Ganesh, M., Asifsha, D., & Venkateswaramurthy, N. (2024) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3243 · Cited by 2
XGRm: A Web Server for Interpreting Mouse Summary-level Genomic Data
Wang, S., Bao, C., Yang, S., Gao, C., Lu, C., Jiang, L., Chen, L., Wang, Z., & Fang, H. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168705 · Cited by 2
Computational design of novel therapeutics targeting Schistosomiasis, a neglected tropical disease
Ibrahim, M. T., Ja’afaru, S. C., Uzairu, A., Chandra, A., Sallau, M. S., & Singh, N. (2024) · Scientific African · doi:10.1016/j.sciaf.2024.e02326 · Cited by 2
Naik, B., & Prusty, D. (2024) · Molecular Simulation · doi:10.1080/08927022.2024.2380031 · Cited by 2
Revolutionizing Cardiovascular Treatments with the Use of AI: Current Status and Future Prospects
Szymańska, K., Szmyt, K., Krasnoborska, J., Samojedny, S., Superson, M., Walczak, K., Wilk-Trytko, K., Zarębska, J., & Duplaga, T. (2024) · Quality in Sport · doi:10.12775/qs.2024.19.53072 · Cited by 4
Yee, C., Chan, Y. L., Utama, R. H., Besnier, M., Engel, M., & Belfiore, L. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.103234 · Cited by 2
Suyo, L. R. C., Paulin, J. P., Gapaz, N. C. L. L., Arevalo, M. B. S., Yongco, V. T. P., & Santiago, L. A. (2024) · Karbala International Journal of Modern Science · doi:10.33640/2405-609x.3364 · Cited by 2
Ulitina, A. S., Сироткина, О. В., Vershinina, E. G., Eskerova, M. F., Babenko, A. Y., & Вавилова, Т. В. (2024) · Russian Journal for Personalized Medicine · doi:10.18705/2782-3806-2024-4-4-295-312 · Cited by 2
Kallurkar, K. V., Thakur, S., Jadhav, H. R., & Bharate, S. B. (2024) · ChemistrySelect · doi:10.1002/slct.202403696 · Cited by 2
Deng, Z., Zhang, L., Sun, C., Liu, Y., & Li, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38488 · Cited by 2
Chmurzyńska, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13868-3.00053-3 · Cited by 2
CYP2C19 Genetic Variants and Major Depressive Disorder: A Systematic Review
Bonasser, L. S. S., Silva, C. M. D. S., Fratelli, C. F., Gontijo, B. R., Seixas, J. M. A., Barreto, L. C. L. D. S., & da Silva, I. C. R. (2024) · Pharmaceuticals · doi:10.3390/ph17111461 · Cited by 2
Ntanzi, N., Khan, R. B., Nxumalo, M. B., & Kumalo, H. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40654 · Cited by 2
A novel in vivo approach to monitoring Cyp3a induction and inhibition by bioluminescent urinalysis
Cali, J. J., Ma, D., Bohm, K., & Klaubert, D. H. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2434645 · Cited by 2
Adhikary, S., Roy, S., Budhathoki, S., Chowdhury, S., Stillwell, A., Basnakian, A. G., Tackett, A. J., Avaritt, N. L., Milad, M., & Alam, M. A. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00719k · Cited by 2
Lim, C. R., Ogawa, S., & Kumari, Y. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01523-z · Cited by 2
Nutraceuticals in Metabolism and Xenobiotics
Banu, H. (2024) · Food bioactive ingredients · doi:10.1007/978-3-031-76481-3_3 · Cited by 2
Biçer, E., Özdemir, N., & Macit, M. (2024) · Russian Journal of Electrochemistry · doi:10.1134/s1023193524700484 · Cited by 2
Hoffmann, M., Sauer, J., Book, M., Ermler, T. F., Fischer, P., Gerlach, S., Beltagi, K., Morgenroth, A., Alexa, R., Kranz, J., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041777 · Cited by 2
Ogwu, M. C., Malík, M., Tlustoš, P., & Patočka, J. (2025) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2025.100323 · Cited by 4
Effects of Crocus sativus and its active constituents on cytochrome P450: a review
Bathaei, P., Imenshahidi, M., Vahdati-Mashhadian, N., & Hosseinzadeh, H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03525-6 · Cited by 2
Tuấn, N. Q., Park, H.-S., Choi, S.-H., Hong, D.-Y., Cheon, J.-Y., Lee, Y., Kim, C.-M., Hong, J., Oh, S., Cho, M., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18040521 · Cited by 3
Kandasamy, T., Sarkar, S., Zochedh, A., Kathiresan, T., & Ghosh, S. S. (2025) · IUBMB Life · doi:10.1002/iub.70020 · Cited by 2
RGN6024 Is a Brain-Penetrant, Small-Molecule Tubulin Destabilizer for the Treatment of Glioblastoma
Patrón, L. A., Yeoman, H., Ramos, J., Risinger, A. L., Gokhale, V. M., & Suzuki, T. C. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-1208 · Cited by 2
Yang, S., Wang, L., Wu, J., Liu, T., Pei, S., Zhou, Q., & Wu, Q. (2025) · ChemBioChem · doi:10.1002/cbic.202500278 · Cited by 2
Kavya, P., Krishnamurthy, S., Bhave, S., Telugu, S., & Gayathri, M. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.142925 · Cited by 2
Phenylethanoid Glycosides in Cistanches: Chemistry, Pharmacokinetic, and Antitumor Properties
Li, J., Cao, X., Lv, J., Zhang, H., Liang, Q., Ren, Y., Tian, J., & Dong, G. (2025) · Food Frontiers · doi:10.1002/fft2.70060 · Cited by 3
Caygill, C. H., Alqurashi, S. O., Adolfi, A., Carson, J., Sturm, A., Evans, D. S., Jinks, J., Dechering, K. J., Reimer, L. J., Pennington, S. H., et al. (2025) · Parasitology · doi:10.1017/s0031182025100322 · Cited by 2
Metadata
- Authors
- Zhao, M., Ma, J., Li, M., Zhang, Y., Jiang, B., Zhao, X., Huai, C., Shen, L., Zhang, N., He, L., & Qin, S.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Institutes for Shanghai Pudong Decoding Life, Shanghai 200135, China
- Corresponding author
- Qin, Shengying
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-11-26
- Volume
- 22
- Issue
- 23
- Pages
- 12808
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8657965
- OpenAlex
- W3216238012
- Cited by
- 1,070
- References
- 124
- Citations by year
- 2026: 255 · 2025: 349 · 2024: 301 · 2023: 134 · 2022: 30
- FWCI
- 20.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Nature Science Foundation of China (81773818, 81273596, 30900799, 81671326)
- National key research and development program (2016YFC0905000, 2016YFC0905002, 2016YFC1200200, 2016YFC0906400)
- 111 project, Shanghai Pujiang Program (17PJD020)
- Shanghai Key Laboratory of Psychotic Disorders (13dz2260500)
- Shanghai Science and Technology Innovation Fund (20DZ2202000, 21002411100)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Keywords
- cytochrome P450, drug metabolism, human drug metabolism, CYP1A2, CYP2C9, CYP2C19, CYP3A4, CYP2D6, CYP2B6, CYP2A6, CYP2E1, CYP1B1, CYP1A1
- MeSH terms
- Animals, Cytochrome P-450 Enzyme System, Pharmaceutical Preparations, Humans, Metabolic Clearance Rate, Inactivation, Metabolic, Polymorphism, Genetic, Xenobiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review